Disclosures: The authors have not received any financial consideration from any person or organization to support the preparation, analysis, results, or discussion of this article.
Correspondence: Eric C. Blackstone, MA, Department of Bioethics, Case Western Reserve University School of Medicine, 10900 Euclid Avenue, Cleveland, OH 44106. Email: ecb85@case.edu
ZafarSY, AbernethyAP. Financial toxicity, part II: how can we help with the burden of treatment-related costs?Oncology (Williston Park)2013;27:253–254, 256.
ZafarSY, AbernethyAP. Financial toxicity, part II: how can we help with the burden of treatment-related costs? Oncology (Williston Park) 2013;27:253–254, 256.)| false
SmithAG. Looming crisis of financial toxicity in neurologic drug pricing: from out-of-pocket to out-of-community costs. Neurology 2023;100:401–402.)| false